CODE is sponsoring the International Forum for Quality Cancer Care (IFQCC) whose vision is to become a world-leading forum in addressing cancer care delivery issues leading to a positive impact on the global efforts for cancer control.
CODE is supporting the creation of the Oncology Data Network (ODN) which has been designed to collate up-to-date information on how anti-cancer medicines are actually being used in clinical practice across Europe. This information can be used to help both inform patient care and address the challenges of financial sustainability.
The Forum will be led by Professor David Kerr Professor of Cancer Medicine at the University of Oxford and Chair of the CODE Clinical and Analytical Steering Committee.
Professor Kerr commented: “We welcome the sponsorship and support from the Collaboration for Oncology Data in Europe (CODE) for the International Forum for Quality Cancer Care (IFQCC) from 8-9 September. There will be key players at the conference from Europe and beyond, who will be eager to learn of the aims and aspirations of CODE, the ODN and how anti-cancer medicines are actually being used in clinical practice across Europe.”
“We are pleased to support this Forum which is addressing issues aligned with our own goals at CODE. It is exciting to see hospitals across Europe joining the Oncology Data Network. They are recognising the need to come together to find new solutions to the challenges of informing quality care and addressing financial sustainability whilst ensuring data protection and patient and physician privacy.” added Dr Ashley Woolmore, CODE Initiative Lead.
Attendees will include oncologists, policy makers, nurses and pharmacists, with the aim to understand health systems and key reforms in cancer policy, sharing experience of existing initiatives to improve quality of cancer care and considering the role of the healthcare industry in responding to the challenge of cancer.
The Forum is taking place at Keble College in Oxford from 8-9 September 2018 and is organised by the Cancer Care Commission. For more information, please visit: http://www.cancercarecommission.com/eventbrite-event/international-forum-for-quality-cancer-care-ifqcc-2018-oxford/
To learn more about the Collaboration for Oncology Data in Europe (CODE), visit www.code-cancer.com. For further enquiries, email us at firstname.lastname@example.org.